NOVEMBER 6: URO TODAY: New research shows there is little medical profession or public support for a US Preventative Services Task Force recommendation to discontinue PSA screening at age 75. READ MORE>
NOVEMBER 6: URO TODAY: Men who stick with prostate screening have a much better chance of not dying of prostate cancer, Swedish researchers have established. READ MORE>
NOVEMBER 6: URO TODAY: Only a few programmes are designed to help couples cope with the effects of prostate cancer, and typically, only their intervention outcomes are reported. READ MORE>
NOVEMBER 6: SCIENCE DAILY: A combination of radiation therapy and chemotherapy given before prostate removal is safe and may have the potential to reduce cancer recurrence and improve patient survival. READ MORE>
NOVEMBER 6: ATLANTA JOURNAL: Prostate cancer patients whose prostate-specific antigen (PSA) levels rise within 18 months after radiotherapy have an increased risk of death, say U.S. researchers. READ MORE>
NOVEMBER 5: URO TODAY: There are no clear associations between red meat and fatal prostate cancer, says a new study of 170,000 US men. [But] red and processed meat may be associated with prostate cancer via mechanisms involving READ MORE>
NOVEMBER 5: URO TODAY: More than two-thirds of men who have radical prostatectomy for prostate cancer end up with a shorter penis – but apparently it’s not a big issue for most, according to new Canadian research. READ MORE>
NOVEMBER 5: URO TODAY: Radiation dose delivered to the prostate and nearby organs in every brachytherapy procedure should be carefully analysed using post-implant CT or MRI and uniformly documented in every patient, according to new brachytherapy guidelines just issued in the US. READ MORE>
NOVEMBER 5: REUTERS: Hypo-fractionated radiation treatment – a newer type of radiation treatment that delivers higher doses of radiation in fewer treatments than conventional radiation therapy – is significantly more effective in stopping prostate cancer from growing in high risk patients. READ MORE>
NOVEMBER 5: SCIENCE DAILY: The size and shape of the blood vessels visible within a prostate cancer tumour may be a useful clue to how the cancer will behave and how it needs to be treated. READ MORE>
NOVEMBER 4: MEDICAL NEWS TODAY: Radiation therapy alone can reduce prostate specific antigen (PSA) levels below detectable amounts in prostate cancer patients, the annual meeting of the American Society for Radiation Oncology has heard. READ MORE>
NOVEMBER 4: NEW PROSTATE CANCER INFOLINK: Long-awaited advanced prostate cancer drug Provenge is a step closer to being available with news the manufacturing company has completed its full application to the FDA. READ MORE>
NOVEMBER 4: URO TODAY: A new study has looked at the relationship between depression caused by prostate cancer and religious beliefs and spirituality. READ MORE>
NOVEMBER 4: URO TODAY: Cholesterol levels and prostate cancer definitely seem to be connected, a new study at Johns Hopkins in Baltimore has revealed. READ MORE>
NOVEMBER 4: URO TODAY: Short-term hormone therapy given prior to and during radiation treatment to medium-risk prostate cancer patients increases their chance of living longer, but there is no significant benefit for low-risk patients. READ MORE>
NOVEMBER 4: URO TODAY: Concerned about recent controversy that disparaged testing for prostate cancer, the American Urological Association has reaffirmed its backing for testing. READ MORE
NOVEMBER 4: SCIENCE CODEX: Men who get a “boost” of proton therapy after receiving a standard course of X-ray radiation therapy have fewer recurrences of their prostate cancer compared to men who do not receive the extra dose of proton radiation. READ MORE>
NOVEMBER 3: URO TODAY: Curcumin – found in Indian spice trumeric – appears to be a non-toxic alternative for prostate cancer prevention, treatment or co-treatment, according to researchers in Luxembourg. READ MORE>
NOVEMBER 2: URO TODAY: What happens to men’s orgasms after nerve-sparing radical prostatectomy for prostate cancer is little researched, so some Italian scientists (who else) have investigated some patients over four years. READ MORE>
NOVEMBER 2: NEW PROSTATE CANCER INFOLINK: If today’s 20-year-olds maintain a regular pattern of exercise throughout their lives, they will reduce their risks for all sorts of problems that are common in society today — prostate cancer included. READ MORE>
NOVEMBER 2: MEDICAL NEWS TODAY: The male hormone androgen may trigger the gene fusion that leads to the development of prostate cancer, according to US researchers. They found that pieces of chromosome that normally sit far apart, relocate near each other after exposure to androgen, and this sets the scene for the genes to fuse. READ MORE>
NOVEMBER 1: URO TODAY: A study comparing Dutch men who got regular PSA testing for prostate cancer with Irish men who didn’t showed a 53% reduction in cancer spread among the Dutch, and a 37% lower death rate from cancer after more than eight years. READ MORE>
NOVEMBER 1: URO TODAY: The number of positive core samples in a biopsy for prostate cancer appears to be related to how successful hormone therapy will be later. READ MORE>
NOVEMBER 1: URO TODAY: Giving newly diagnosed prostate cancer patients a bone scan has dropped off dramatically since the advent of PSA tests, but new research suggests reading PSA levels and Gleason score can accurately predict when bone scans are needed. READ MORE>
